A novel in silico reverse-transcriptomics-based identification and blood-based validation of a panel of sub-type specific biomarkers in lung cancer

[1]  M. Mori,et al.  Cancer‐associated upregulation of histone H3 lysine 9 trimethylation promotes cell motility in vitro and drives tumor formation in vivo , 2013, Cancer science.

[2]  Jan-Gowth Chang,et al.  High expressions of histone methylation- and phosphorylation-related proteins are associated with prognosis of oral squamous cell carcinoma in male population of Taiwan , 2013, Medical Oncology.

[3]  D. Calvisi,et al.  Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression , 2012, Hepatology.

[4]  Michael F. Ochs,et al.  Serum microRNA Biomarkers for Detection of Non-Small Cell Lung Cancer , 2012, PloS one.

[5]  M. Ceccarelli,et al.  Signaling Networks Associated with AKT Activation in Non-Small Cell Lung Cancer (NSCLC): New Insights on the Role of Phosphatydil-Inositol-3 kinase , 2012, PloS one.

[6]  Q. Pang,et al.  HMGA1 expression in human gliomas and its correlation with tumor proliferation, invasion and angiogenesis , 2012, Journal of Neuro-Oncology.

[7]  C. Iacobuzio-Donahue,et al.  HMGA1 Induces Intestinal Polyposis in Transgenic Mice and Drives Tumor Progression and Stem Cell Properties in Colon Cancer Cells , 2012, PloS one.

[8]  W. Jiang,et al.  Histone-modifier gene expression profiles are associated with pathological and clinical outcomes in human breast cancer. , 2011, Anticancer research.

[9]  Lei Zhang,et al.  Proteomic Analysis of Human Saliva From Lung Cancer Patients Using Two-Dimensional Difference Gel Electrophoresis and Mass Spectrometry* , 2011, Molecular & Cellular Proteomics.

[10]  Norbert Gretz,et al.  miRWalk - Database: Prediction of possible miRNA binding sites by "walking" the genes of three genomes , 2011, J. Biomed. Informatics.

[11]  B. Karger,et al.  Discovery of Lung Cancer Biomarkers by Profiling the Plasma Proteome with Monoclonal Antibody Libraries , 2011, Molecular & Cellular Proteomics.

[12]  Patrick Maisonneuve,et al.  A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer , 2011, EMBO molecular medicine.

[13]  Iver Petersen,et al.  The morphological and molecular diagnosis of lung cancer. , 2011, Deutsches Arzteblatt international.

[14]  T. Ma,et al.  High-mobility group A1 proteins enhance the expression of the oncogenic miR-222 in lung cancer cells , 2011, Molecular and Cellular Biochemistry.

[15]  G. M. Wilson,et al.  Modulation of neoplastic gene regulatory pathways by the RNA-binding factor AUF1. , 2011, Frontiers in bioscience.

[16]  S. Goodman,et al.  An Epigenetic Marker Panel for Detection of Lung Cancer Using Cell-Free Serum DNA , 2011, Clinical Cancer Research.

[17]  Peter Wernet,et al.  MicroRNAs MiR-17, MiR-20a, and MiR-106b Act in Concert to Modulate E2F Activity on Cell Cycle Arrest during Neuronal Lineage Differentiation of USSC , 2011, PloS one.

[18]  Feng Jiang,et al.  Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers , 2010, International journal of cancer.

[19]  S. Dacic,et al.  miRNA expression profiling of lung adenocarcinomas: correlation with mutational status , 2010, Modern Pathology.

[20]  Chi-Ying F. Huang,et al.  miRTarBase: a database curates experimentally validated microRNA–target interactions , 2010, Nucleic Acids Res..

[21]  F. Jiang,et al.  A Panel of Sputum-Based Genomic Marker for Early Detection of Lung Cancer , 2010, Cancer Prevention Research.

[22]  J. Benítez,et al.  Gene amplification of the transcription factor DP1 and CTNND1 in human lung cancer , 2010, The Journal of pathology.

[23]  Angela Re,et al.  CircuitsDB: a database of mixed microRNA/transcription factor feed-forward regulatory circuits in human and mouse , 2010, BMC Bioinformatics.

[24]  Iris Barshack,et al.  MicroRNA expression differentiates between primary lung tumors and metastases to the lung. , 2010, Pathology, research and practice.

[25]  D. Barh,et al.  miReg: a resource for microRNA regulation , 2010, J. Integr. Bioinform..

[26]  Zhenqiu Liu,et al.  Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer , 2010, Molecular Cancer.

[27]  C. Pecquet,et al.  miR-28 is a thrombopoietin receptor targeting microRNA detected in a fraction of myeloproliferative neoplasm patient platelets. , 2010, Blood.

[28]  F. Jiang,et al.  Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers , 2010, Modern Pathology.

[29]  R. Clarke,et al.  Frequent loss of heterozygosity at the interferon regulatory factor-1 gene locus in breast cancer , 2010, Breast Cancer Research and Treatment.

[30]  Xi Chen,et al.  Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  Malik Yousef,et al.  Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease. , 2009, Cancer research.

[32]  E. Cho,et al.  The tumor suppressor, parafibromin, mediates histone H3 K9 methylation for cyclin D1 repression , 2009, Nucleic acids research.

[33]  Jeanne Kowalski,et al.  Upregulation of MMP-2 by HMGA1 Promotes Transformation in Undifferentiated, Large-Cell Lung Cancer , 2009, Molecular Cancer Research.

[34]  Zsolt Czimmerer,et al.  DIFFERENTIALLY EXPRESSED MicroRNAs IN SMALL CELL LUNG CANCER , 2009, Experimental lung research.

[35]  M. Nakao,et al.  HMGA1 is induced by Wnt/beta-catenin pathway and maintains cell proliferation in gastric cancer. , 2009, The American journal of pathology.

[36]  Ming Lu,et al.  TransmiR: a transcription factor–microRNA regulation database , 2009, Nucleic Acids Res..

[37]  D. Beer,et al.  MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. , 2009, Cancer research.

[38]  E. Dmitrovsky,et al.  Tumor-Suppressive microRNAs in Lung Cancer: Diagnostic and Therapeutic Opportunities , 2009, TheScientificWorldJournal.

[39]  Jing Chen,et al.  ToppGene Suite for gene list enrichment analysis and candidate gene prioritization , 2009, Nucleic Acids Res..

[40]  Yan Wang,et al.  VisANT 3.5: multi-scale network visualization, analysis and inference based on the gene ontology , 2009, Nucleic Acids Res..

[41]  A. Bosio,et al.  Transcriptional profiling identifies an interferon‐associated host immune response in invasive squamous cell carcinoma of the skin , 2008, International journal of cancer.

[42]  Tongbin Li,et al.  miRecords: an integrated resource for microRNA–target interactions , 2008, Nucleic Acids Res..

[43]  A. Ishizaka,et al.  Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells , 2008, Cancer Cell International.

[44]  Yadong Wang,et al.  miR2Disease: a manually curated database for microRNA deregulation in human disease , 2008, Nucleic Acids Res..

[45]  Huang-Tian Yang,et al.  E2F6 inhibits cobalt chloride-mimetic hypoxia-induced apoptosis through E2F1. , 2008, Molecular biology of the cell.

[46]  L. Lanting,et al.  Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes , 2008, Proceedings of the National Academy of Sciences.

[47]  Xiaowei Wang.  miRDB: a microRNA target prediction and functional annotation database with a wiki interface. , 2008, RNA.

[48]  J. Inazawa,et al.  Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. , 2008, Cancer research.

[49]  Sung-Liang Yu,et al.  MicroRNA signature predicts survival and relapse in lung cancer. , 2008, Cancer cell.

[50]  Wendy Cozen,et al.  Identification of a panel of sensitive and specific DNA methylation markers for lung adenocarcinoma , 2007, Molecular Cancer.

[51]  F. Kittrell,et al.  Identification of novel amplification gene targets in mouse and human breast cancer at a syntenic cluster mapping to mouse ch8A1 and human ch13q34. , 2007, Cancer research.

[52]  E. Miska,et al.  miRNAs in cancer: approaches, aetiology, diagnostics and therapy. , 2007, Human molecular genetics.

[53]  S. Knuutila,et al.  Increased expression of high mobility group A proteins in lung cancer , 2006, The Journal of pathology.

[54]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[55]  R. Stephens,et al.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. , 2006, Cancer cell.

[56]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[57]  Y. Yatabe,et al.  A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. , 2005, Cancer research.

[58]  James L Mulshine,et al.  Lung cancer screening. , 2005, The oncologist.

[59]  P. Dennis,et al.  An overview of lung cancer genomics and proteomics. , 2005, American journal of respiratory cell and molecular biology.

[60]  J. Inazawa,et al.  Association of over-expressed TFDP1 with progression of hepatocellular carcinomas , 2003, Journal of Human Genetics.

[61]  M. Tyers,et al.  Osprey: a network visualization system , 2003, Genome Biology.

[62]  F. Yehiely,et al.  Cell Death Inhibiting RNA (CDIR) Derived from a 3′-Untranslated Region Binds AUF1 and Heat Shock Protein 27* , 2002, The Journal of Biological Chemistry.

[63]  L. Dwyer-Nield,et al.  Differential Expression and Localization of the mRNA Binding Proteins, AU‐Rich Element mRNA Binding Protein (AUF1) and Hu Antigen R (HuR), in Neoplastic Lung Tissue , 2000, Molecular carcinogenesis.

[64]  J. Usuda,et al.  Molecular determinants of UCN‐01‐induced growth inhibition in human lung cancer cells , 2000, International journal of cancer.

[65]  J. Jorcano,et al.  Differential expression and functionally co-operative roles for the retinoblastoma family of proteins in epidermal differentiation , 1998, Oncogene.

[66]  T. Taniguchi,et al.  Functionally inactivating point mutation in the tumor‐suppressor IRF‐1 gene identified in human gastric cancer , 1998, International journal of cancer.

[67]  D. Livingston,et al.  Unusual proliferation arrest and transcriptional control properties of a newly discovered E2F family member, E2F-6. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[68]  A. Giordano,et al.  Differential expression of the retinoblastoma gene family members pRb/p105, p107, and pRb2/p130 in lung cancer. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[69]  W. Lee,et al.  The molecular basis of E2F-1/DP-1-induced S-phase entry and apoptosis. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[70]  M. Ewen,et al.  Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. , 1993, Genes & development.

[71]  D. Harpole,et al.  Molecular markers for incidence, prognosis, and response to therapy. , 2012, Surgical oncology clinics of North America.

[72]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[73]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[74]  B. Teicher,et al.  Expression of pRB, cyclin/cyclin-dependent kinases and E2F1/DP-1 in human tumor lines in cell culture and in xenograft tissues and response to cell cycle agents , 2000, Cancer Chemotherapy and Pharmacology.

[75]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.